These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. [Comparison between clinical information capability of increased alpha-fetoprotein values in amniotic fluid and in maternal serum (author's transl)]. Hemke G; Weise W Zentralbl Gynakol; 1981; 103(11):617-23. PubMed ID: 6168142 [TBL] [Abstract][Full Text] [Related]
31. Raised levels of maternal serum secretory acetylcholinesterase may be indicative of fetal neural tube defects in early pregnancy. Brennand DM; Jehanli AM; Wood PJ; Smith JL Acta Obstet Gynecol Scand; 1998 Jan; 77(1):8-13. PubMed ID: 9492710 [TBL] [Abstract][Full Text] [Related]
32. [Antenatal screening for neural tube defect by measuring alphafetoprotein in dried blood eluates (author's transl)]. Augier D; Dutau G; Petrus M; Grandjean H; Pontonnier G; Rochiccioli P Arch Fr Pediatr; 1981 Dec; 38(10):757-60. PubMed ID: 6174100 [TBL] [Abstract][Full Text] [Related]
33. Insulin-dependent diabetes mellitus and prenatal screening results: current experience from a regional screening programme. Crossley JA; Berry E; Aitken DA; Connor JM Prenat Diagn; 1996 Nov; 16(11):1039-42. PubMed ID: 8953638 [TBL] [Abstract][Full Text] [Related]
34. Serum markers for Down's syndrome in relation to number of previous births and maternal age. Wald NJ; Watt HC Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278 [TBL] [Abstract][Full Text] [Related]
35. [Prenatal maternal blood screening for the detection of fetal chromosomal abnormalities: clinical importance of the rate of false positives]. Alvarez-Nava F; Soto M; Padrón T; Morales A; Villalobos D; Rojas de Atencio A; Prieto M; Martínez MC Invest Clin; 2003 Sep; 44(3):195-207. PubMed ID: 14552058 [TBL] [Abstract][Full Text] [Related]
36. [Solid-phase immunoenzyme analysis of alpha-fetoprotein in human blood serum]. Shevtsova AI; Demchenko TV; Lapa TV Lab Delo; 1990; (5):52-5. PubMed ID: 1695975 [TBL] [Abstract][Full Text] [Related]
37. Influence of laboratory test volume and geographic location on maternal alpha-fetoprotein results. Information from the College of American Pathologists Maternal alpha-fetoprotein Survey. Eckfeldt JH; Long TA Arch Pathol Lab Med; 1991 Jul; 115(7):647-53. PubMed ID: 1712194 [TBL] [Abstract][Full Text] [Related]
38. Comparison of an ELISA with a RIA method for serum alpha-fetoprotein determination in screening for fetal neural tube defects. Barlow RD; Thompson SG; Cuckle HS; Wald NJ; Voller A Ann Clin Biochem; 1986 May; 23 ( Pt 3)():334-9. PubMed ID: 2431649 [TBL] [Abstract][Full Text] [Related]
39. [Significant effects on alpha-fetoprotein (AFP) concentration in maternal serum in pregnancy]. Greiff R; Schlosser H; Amse T Zentralbl Gynakol; 1991; 113(5):253-7. PubMed ID: 1711749 [TBL] [Abstract][Full Text] [Related]
40. Implementation of a screening program for diagnosing open neural tube defects: selection, evaluation, and utilization of alpha-fetoprotein methodology. Christensen RL; Rea MR; Kessler G; Crane JP; Valdes R Clin Chem; 1986 Oct; 32(10):1812-7. PubMed ID: 2428543 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]